Manulife (Manufacturers Life Insurance)’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,743
| Closed | -$1.28M | – | 3040 |
|
|
2022
Q3 | $1.28M | Sell |
24,743
-963
| -4% | -$39.8K | ﹤0.01% | 1506 |
|
|
2022
Q2 | $637K | Buy |
25,706
+3,069
| +14% | +$67.6K | ﹤0.01% | 1885 |
|
|
2022
Q1 | $568K | Sell |
22,637
-5,043
| -18% | -$142K | ﹤0.01% | 2126 |
|
|
2021
Q4 | $1.01K | Sell |
27,680
-1,368
| -5% | -$48K | ﹤0.01% | 1820 |
|
|
2021
Q3 | $497K | Sell |
29,048
-2,502
| -8% | -$39K | ﹤0.01% | 2290 |
|
|
2021
Q2 | $422K | Buy |
31,550
+3,478
| +12% | +$85.7K | ﹤0.01% | 2562 |
|
|
2021
Q1 | $1.44M | Sell |
28,072
-1,751
| -6% | -$105K | ﹤0.01% | 1690 |
|
|
2020
Q4 | $1.85M | Buy |
29,823
+1,265
| +4% | +$72.4K | ﹤0.01% | 1558 |
|
|
2020
Q3 | $1.56M | Buy |
28,558
+1,841
| +7% | +$99.1K | ﹤0.01% | 1498 |
|
|
2020
Q2 | $1.46M | Buy |
26,717
+470
| +2% | +$25.6K | ﹤0.01% | 1486 |
|
|
2020
Q1 | $1.05M | Buy |
26,247
+732
| +3% | +$31.1K | ﹤0.01% | 1498 |
|
|
2019
Q4 | $1.01M | Sell |
25,515
-1,168
| -4% | -$20.5K | ﹤0.01% | 1678 |
|
|
2019
Q3 | $175K | Hold |
26,683
| – | – | ﹤0.01% | 2654 |
|
|
2019
Q2 | $248K | Buy |
+26,683
| New | +$309K | ﹤0.01% | 2491 |
|
|
2018
Q3 | – | Sell |
-18,218
| Closed | -$240K | – | 4039 |
|
|
2018
Q2 | $240K | Sell |
18,218
-2,134
| -10% | -$25.5K | ﹤0.01% | 2981 |
|
|
2018
Q1 | $276K | Buy |
20,352
+11,902
| +141% | +$123K | ﹤0.01% | 2774 |
|
|
2017
Q4 | $50K | Sell |
8,450
-12,987
| -61% | -$89.1K | ﹤0.01% | 3548 |
|
|
2017
Q3 | $159K | Sell |
21,437
-1,077
| -5% | -$8.95K | ﹤0.01% | 3162 |
|
|
2017
Q2 | $211K | Buy |
22,514
+2,852
| +15% | +$20.9K | ﹤0.01% | 2966 |
|
|
2017
Q1 | $144K | Buy |
19,662
+1,718
| +10% | +$12.4K | ﹤0.01% | 3023 |
|
|
2016
Q4 | $133K | Buy |
17,944
+16,605
| +1,240% | +$120K | ﹤0.01% | 3075 |
|
|
2016
Q3 | $8K | Hold |
1,339
| – | – | ﹤0.01% | 3754 |
|
|
2016
Q2 | $6K | Sell |
1,339
-19,752
| -94% | -$74.1K | ﹤0.01% | 3776 |
|
|
2016
Q1 | $49K | Buy |
21,091
+2,302
| +12% | +$8.38K | ﹤0.01% | 3293 |
|
|
2015
Q4 | $152 | Hold |
18,789
| – | – | ﹤0.01% | 2863 |
|
|
2015
Q3 | $113 | Hold |
18,789
| – | – | ﹤0.01% | 3065 |
|
|
2015
Q2 | $155 | Sell |
18,789
-660
| -3% | -$5.24K | ﹤0.01% | 3079 |
|
|
2015
Q1 | $146 | Buy |
19,449
+7,863
| +68% | +$61.4K | ﹤0.01% | 2969 |
|
|
2014
Q4 | $80 | Sell |
11,586
-7,298
| -39% | -$38.6K | ﹤0.01% | 3132 |
|
|
2014
Q3 | $85 | Buy |
18,884
+10,855
| +135% | +$57.4K | ﹤0.01% | 3172 |
|
|
2014
Q2 | $47K | Sell |
8,029
-12,670
| -61% | -$71.1K | ﹤0.01% | 3265 |
|
|
2014
Q1 | $138 | Hold |
20,699
| – | – | ﹤0.01% | 2930 |
|
|
2013
Q4 | $120 | Buy |
20,699
+1,227
| +6% | +$6.33K | ﹤0.01% | 2998 |
|
|
2013
Q3 | $108 | Buy |
19,472
+653
| +3% | +$7.06K | ﹤0.01% | 3014 |
|
|
2013
Q2 | $266K | Buy |
+18,819
| New | +$244K | ﹤0.01% | 2346 |
|
Other funds holding CCXI
Manulife (Manufacturers Life Insurance)'s CCXI Position: Q4 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 24,743 shares — an estimated $1.28M sold.
Manulife (Manufacturers Life Insurance) first reported a position in CCXI in Q2 2013 and held it in 35 quarters. The position peaked at $1.85M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 24,743 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.28M.
- Manulife (Manufacturers Life Insurance) first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 35 quarters.
- Manulife (Manufacturers Life Insurance)'s ChemoCentryx, Inc. position peaked at $1.85M in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.